Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A systematic review and meta-analysis of the incidence of post-thrombotic syndrome, recurrent thromboembolism, and bleeding after upper extremity vein thrombosis.
Espitia O, Raimbeau A, Planquette B, Katsahian S, Sanchez O, Espinasse B, Bénichou A, Murris J. Espitia O, et al. Among authors: murris j. J Vasc Surg Venous Lymphat Disord. 2024 Jan;12(1):101688. doi: 10.1016/j.jvsv.2023.09.002. Epub 2023 Sep 16. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 37717788 Free PMC article.
Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and are associated with poor clinical outcome in NSCLC.
Devi-Marulkar P, Fastenackels S, Karapentiantz P, Goc J, Germain C, Kaplon H, Knockaert S, Olive D, Panouillot M, Validire P, Damotte D, Alifano M, Murris J, Katsahian S, Lawand M, Dieu-Nosjean MC. Devi-Marulkar P, et al. Among authors: murris j. Commun Biol. 2022 Dec 24;5(1):1416. doi: 10.1038/s42003-022-04356-y. Commun Biol. 2022. PMID: 36566320 Free PMC article.
Risk factors for thromboembolic events in patients hospitalized for COVID-19 pneumonia in a general ward and requiring treatment with oxygen.
Degrave R, Murris J, Charles-Nelson A, Hermine O, Porcher R, Ravaud P, Mariette X, Tharaux PL, Resche-Rigon M, Sanchez O, Katsahian S; CORIMUNO-19 Collaborative Group; Arlet JB. Degrave R, et al. Among authors: murris j. Postgrad Med J. 2024 Jan 21;100(1180):120-126. doi: 10.1093/postmj/qgad104. Postgrad Med J. 2024. PMID: 37978265 Clinical Trial.
Evolution of minimally invasive liver surgery in France over the last decade.
Deyrat J, Fuks D, Murris J, Lanoy E, Nassar A, Dhote A, Marchese U, Mallet V, Katsahian S, Gaillard M, Tzedakis S. Deyrat J, et al. Among authors: murris j. Surg Endosc. 2024 Aug;38(8):4457-4467. doi: 10.1007/s00464-024-10951-3. Epub 2024 Jun 20. Surg Endosc. 2024. PMID: 38902411
Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people.
Poisson J, El-Sissy C, Serret-Larmande A, Smith N, Lebraud M, Augy JL, Conti C, Gonnin C, Planquette B, Arlet JB, Hermann B, Charbit B, Pastre J, Devaux F, Ladavière C, Lim L, Ober P, Cannovas J, Biard L, Gulczynski MC, Blumenthal N, Péré H, Knosp C, Gey A, Benhamouda N, Murris J, Veyer D, Tartour E, Diehl JL, Duffy D, Paillaud E, Granier C. Poisson J, et al. Among authors: murris j. Immun Ageing. 2024 May 7;21(1):28. doi: 10.1186/s12979-024-00430-7. Immun Ageing. 2024. PMID: 38715114 Free PMC article.
Protocol for fever control using external cooling in mechanically ventilated patients with septic shock: SEPSISCOOL II randomised controlled trial.
Guénégou-Arnoux A, Murris J, Bechet S, Jung C, Auchabie J, Dupeyrat J, Anguel N, Asfar P, Badie J, Carpentier D, Chousterman B, Bourenne J, Delbove A, Devaquet J, Deye N, Dumas G, Dureau AF, Lascarrou JB, Legriel S, Guitton C, Jannière-Nartey C, Quenot JP, Lacherade JC, Maizel J, Mekontso Dessap A, Mourvillier B, Petua P, Plantefeve G, Richard JC, Robert A, Saccheri C, Vong LVP, Katsahian S, Schortgen F; REVA Network. Guénégou-Arnoux A, et al. Among authors: murris j. BMJ Open. 2024 Jan 29;14(1):e069430. doi: 10.1136/bmjopen-2022-069430. BMJ Open. 2024. PMID: 38286691 Free PMC article.
Corrigendum to 'Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)' [European Journal of Cancer 152 (2021) 116-128].
Gogas H, Dummer R, Ascierto PA, Arance A, Mandalà M, Liszkay G, Garbe C, Schadendorf D, Krajsová I, Gutzmer R, Chiarion Sileni V, Dutriaux C, Yamazaki N, Loquai C, Queirolo P, de Willem GJ, Sellier AT, Suissa J, Murris J, Gollerkeri A, Robert C, Flaherty KT. Gogas H, et al. Among authors: murris j. Eur J Cancer. 2022 Jan;160:287-288. doi: 10.1016/j.ejca.2021.10.002. Epub 2021 Oct 28. Eur J Cancer. 2022. PMID: 34756500 No abstract available.
Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS).
Gogas H, Dummer R, Ascierto PA, Arance A, Mandalà M, Liszkay G, Garbe C, Schadendorf D, Krajsová I, Gutzmer R, Sileni VC, Dutriaux C, Yamazaki N, Loquai C, Queirolo P, Jan de Willem G, Sellier AT, Suissa J, Murris J, Gollerkeri A, Robert C, Flaherty KT. Gogas H, et al. Among authors: murris j. Eur J Cancer. 2021 Jul;152:116-128. doi: 10.1016/j.ejca.2021.04.028. Epub 2021 Jun 4. Eur J Cancer. 2021. PMID: 34091420 Clinical Trial.